Julie C Price
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julie C Price has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad R. Hariri
Duke University
1 shared publication - Amy Kathleen Wagner
Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
1 shared publication Anne C Ritter
Department of Physical Medicine and Rehabilitation, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
1 shared publication- Carl Becker
Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA
1 shared publication Carl R Becker
Department of Radiology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
1 shared publication- Carolyn Cidis Meltzer
From the RSNA Board of Directors
1 shared publication
Latest Publications
- 21 May 2014
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 34 (8) , 1328-1339
The Influence of Genetic Variants on Striatal Dopamine Transporter and D2 Receptor Binding after TB
Dopamine (DA) neurotransmission influences cognition and recovery after traumatic brain injury (TBI). We explored whether functional genetic variants affecting the DA transporter (DAT) and D2 receptor (DRD2) impacted in vivo dopaminergic binding with positron emission tomography (PET) using [11C]βCFT and [11C]raclopride. We examined subjects with moderate/severe TBI ( N = 12) ~1 year post injury and similarly matched healthy controls ( N = 13). The variable number of tandem repeat polymorphism within the DAT gene and the Taql restriction fragment length polymorphism near the DRD2 gene were assessed. TBI subjects had age-adjusted DAT-binding reductions in the caudate, putamen, and ventral striatum, and modestly increased D2 binding in ventral striatum versus controls. Despite small sample sizes, multivariate analysis showed lower caudate and putamen DAT binding among DAT 9-allele carriers and DRD2 A2/A2 homozygotes with TBI versus controls with the same genotype. Among TBI subjects, 9-allele carriers had lower caudate and putamen binding than 10/10 homozygotes. This PET study suggests a hypodopaminergic environment and altered DRD2 autoreceptor DAT interactions that may influence DA transmission after TBI. Future work will relate these findings to cognitive performance; future studies are required to determine how DRD2/DAT1 genotype and DA-ligand binding are associated with neurostimulant response and TBI recovery.
- 21 May 2014
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 34 (8) , 1328-1339
The Influence of Genetic Variants on Striatal Dopamine Transporter and D2 Receptor Binding after TB
Dopamine (DA) neurotransmission influences cognition and recovery after traumatic brain injury (TBI). We explored whether functional genetic variants affecting the DA transporter (DAT) and D2 receptor (DRD2) impacted in vivo dopaminergic binding with positron emission tomography (PET) using [11C]βCFT and [11C]raclopride. We examined subjects with moderate/severe TBI ( N = 12) ~1 year post injury and similarly matched healthy controls ( N = 13). The variable number of tandem repeat polymorphism within the DAT gene and the Taql restriction fragment length polymorphism near the DRD2 gene were assessed. TBI subjects had age-adjusted DAT-binding reductions in the caudate, putamen, and ventral striatum, and modestly increased D2 binding in ventral striatum versus controls. Despite small sample sizes, multivariate analysis showed lower caudate and putamen DAT binding among DAT 9-allele carriers and DRD2 A2/A2 homozygotes with TBI versus controls with the same genotype. Among TBI subjects, 9-allele carriers had lower caudate and putamen binding than 10/10 homozygotes. This PET study suggests a hypodopaminergic environment and altered DRD2 autoreceptor DAT interactions that may influence DA transmission after TBI. Future work will relate these findings to cognitive performance; future studies are required to determine how DRD2/DAT1 genotype and DA-ligand binding are associated with neurostimulant response and TBI recovery.
- Open Access
- 17 October 2012
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (S2) , A31
Positron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
- 17 October 2012
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 10 (S2) , A31
Open AccessPositron emission tomography imaging of amyloid-beta plaque deposition: a decade of translation
- Open Access
- 27 September 2011
- Published by Springer Nature in Biology of Mood & Anxiety Disorders
- Vol. 1 (1) , 2
Medial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity
The amygdala and medial prefrontal cortex (mPFC) comprise a key corticolimbic circuit that helps shape individual differences in sensitivity to threat and the related risk for psychopathology. Although serotonin (5-HT) is known to be a key modulator of this circuit, the specific receptors mediating this modulation are unclear. The colocalization of 5-HT1A and 5-HT2A receptors on mPFC glutamatergic neurons suggests that their functional interactions may mediate 5-HT effects on this circuit through top-down regulation of amygdala reactivity. Using a multimodal neuroimaging strategy in 39 healthy volunteers, we determined whether threat-related amygdala reactivity, assessed with blood oxygen level-dependent functional magnetic resonance imaging, was significantly predicted by the interaction between mPFC 5-HT1A and 5-HT2A receptor levels, assessed by positron emission tomography.
- 27 September 2011
- Published by Springer Nature in Biology of Mood & Anxiety Disorders
- Vol. 1 (1) , 2
Open AccessMedial prefrontal cortex serotonin 1A and 2A receptor binding interacts to predict threat-related amygdala reactivity
The amygdala and medial prefrontal cortex (mPFC) comprise a key corticolimbic circuit that helps shape individual differences in sensitivity to threat and the related risk for psychopathology. Although serotonin (5-HT) is known to be a key modulator of this circuit, the specific receptors mediating this modulation are unclear. The colocalization of 5-HT1A and 5-HT2A receptors on mPFC glutamatergic neurons suggests that their functional interactions may mediate 5-HT effects on this circuit through top-down regulation of amygdala reactivity. Using a multimodal neuroimaging strategy in 39 healthy volunteers, we determined whether threat-related amygdala reactivity, assessed with blood oxygen level-dependent functional magnetic resonance imaging, was significantly predicted by the interaction between mPFC 5-HT1A and 5-HT2A receptor levels, assessed by positron emission tomography.